Foot-and-mouth disease vaccine potency testing: Determination and statistical validation of a model using a serological approach

Vaccine

Volumn 21, Issue 23, 2003, Pages 3240-3248

  Barnett, Paul V ^a   Statham, Robert J ^a   Vosloo, Wilna ^b   Haydon, Daniel T ^c  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b ONDERSTEPOORT VETERINARY INSTITUTE   (South Africa)

^c UNIVERSITY OF GUELPH   (Canada)

Author keywords

Antibody titre; Challenge test; Foot and mouth disease; Logistic regression; Potency; Vaccine

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CATTLE; DRUG DETERMINATION; DRUG EFFICACY; DRUG MANUFACTURE; DRUG POTENCY; DRUG SCREENING; LOGISTIC REGRESSION ANALYSIS; MEDICAL LITERATURE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEROLOGY; SEROTYPE; STATISTICAL ANALYSIS; STATISTICAL MODEL; VACCINATION;

EID: 0038797783     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00219-6     Document Type: Article

References (24)

1. European Pharmacopoeia 1997. Foot-and-Mouth Disease (Ruminants) Vaccine 1997;63:875-6.
2. Pay T.W.F., Hingley P.J. The use of serum neutralising antibody assay for the determination of the potency of foot-and-mouth disease vaccines in cattle. Develop. Biol. Stand. 64:1986;153-161.
3. van Bekkum JG. Neutraliserende antistoffen in sera van regen mond and Klauwzeer geente runderen. Thesis. University of Utrecht, Utrecht, 1959.
4. Hecke F., Uhlmann W., Lorenz R. Bericht uber die ergebnisse der grossversuchs 1957-1958 zur wirkaamkeitsprufung der Maul-und klavenseuche-koncentratvakzine nach pyl unf der originalvakzine nach waldmann und kobe. IV. Beziehung zwischen serumneutralisation und immunitat. Mh. Tierheildk. 12:1960;1-11.
5. Mackowiak C., Lang R., Fontaine J., Camand R., Petermann M.B. Relation entre titre d'anticorps neutralisants et protection des animaux après vaccination antiaphteuse. Ann. Ins. Pasteur. 103:1962;252-261.
6. Bercan A., Muntiu N., Dohotaru U., Tomescu A. Sur la corrélation entre le test de séro-neutralization sur sourceux et immunisation anti-aphtheuse croísee chez les bovins. Bull. Off. Int. Epizoot. 71:1969;381-392.
7. Stellman C., Bornarel P., Lang R., Terre J. Controle quantitatif du vaccin antiaphtheux. Analyse statistique de la relation liant les titres d'anticorps neutralisant au pourcentage de protection bovine. Rec. Med. Vet. (Alfort). 144:1968;325-351.
8. Pay T.W.F., Parker N.J. Some statistical and experimental design problems in the assessment of FMDV vaccine potency. Develop. Biol. Stand. 35:1977;369-383.
9. Pay T.W.F., Hingley P.J. Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines. Vaccine. 5:1987;60-64.
10. Ahl R, Haas B, Lorenz RJ, Wittman G. Assessment of potency of foot-and-mouth disease vaccines by means of antibody assays with sera from vaccinated cattle. Report of the Meeting of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease. Prague, Czechoslovakia, FAO, Rome, Appendix 17, 20-23 September 1988. p. 99-111.
11. Bengelsdorff H.J. Testing the efficacy of FMD vaccines: relationships between test infection results and corresponding neutralization titres of vaccinated cattle. Berliner und Munchener Tierarztliche Wochenschrift. 102:1989;193-198.
12. van Maanen C, Terpstra C. Comparison of the liquid phase blocking sandwich ELISA and the serum neutralisation test to evaluate immunity in potency tests for foot-and-mouth disease vaccines. Session of the Research Group of the European Commission for the Control of Foot-and-Mouth Disease. Prague, Czechoslovakia, FAO, Rome, 20-23 September 1989. p. 91-8.
13. Barnett P.V., Carabin H. A review of emergency foot-and-mouth disease (FMD) vaccines. Vaccine. 20:2002;1505-1514.
14. Anon. Manual of Standards for Diagnostic Tests and Vaccines. Office International des Epizooties. 4th ed. Part 2. Section 2.1. OIE Listed Diseases. Foot-and-Mouth Disease, 2000, Chapter 2.1.1. p. 77-92.
15. Finney DJ. Probit analysis. 3rd ed. London: Cambridge University Press; 1971.
16. Sokal RR, Rolf FJ. Biometry. 3rd ed. New York: Freeman; 1995.
17. Feller W. An introduction to probability theory and its applications. New York: Wiley; 1968.
18. Ahl R, Wittmann G. Further studies on the assessment of potency of FMD vaccines by means of antibody assays with sera from vaccinated cattle. Report of the Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease. Rio de Janeiro, Brazil, FAO, Rome, Appendix 6, 15-18 October 1985. p. 45-9.
19. Sutmoller P., Vieira A. The relationship of neutralizing antibody titres for FMDV and the protection of cattle. Boletin del Centro Panamericano de Fiebre Aftosa. 39-40:1980;57-62.
20. Karber G. Beitrag zur kollekiven Behandlung pharmakologischer Reihenversuche. Arche. Exp. Pathol. Pharmakol. 162:1931;480.
21. Hendriksen CFM. Laboratory animals in vaccine production and control: replacement, reduction and refinement. Dordretch: Kluwer Academic Publishers; 1988.
22. Sutmöller P., Gomes I., Astudillo V.M. Potency estimation of FMD vaccines according to antibody assay results. Boletin del Centro Panamericano Fiebre Aftosa. 45-50:1984;31-34.
23. Ahl R, Haas B, Lorenz RJ, Wittman G. Alternative potency test of FMD vaccines and results of comparative antibody assays in different cell systems and ELISA. Report of the Meeting of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease. Lindholm, Denmark; FAO, Rome, June 1990. p. 51-60.
24. Pay T.W.F., Hingley P.J. Foot-and-mouth disease vaccine potency tests in cattle: the interrelationship of antigen dose, serum neutralizing antibody response and protection from challenge. Vaccine. 10:1992;699-706.